Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Assurance HealthcareFRA:7IQ EV-to-EBITDA is -31.01 as of Aug. 19, 2026. The stock has 4 warning signs investors should review. Among 1,962 Software companies, Assurance Healthcare ranks worse than 50968.35% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Assurance Healthcare's enterprise value is €13.40 Mil.
Assurance Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.43 Mil. Therefore, Assurance Healthcare's EV-to-EBITDA for today is -31.01.
The historical rank and industry rank for Assurance Healthcare's EV-to-EBITDA or its related term are showing as below:
FRA:7IQ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1841.42 Med: -10.6 Max: 128.74
Current: -30.72
During the past 13 years, the highest EV-to-EBITDA of Assurance Healthcare was 128.74. The lowest was -1841.42. And the median was -10.60.
FRA:7IQ's EV-to-EBITDA is ranked worse than 100% of 1962
companies
in the Software industry
Industry Median: 10.405
vs FRA:7IQ: -30.72
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Assurance Healthcare's PE Ratio (TTM) for today is calculated as:
Assurance Healthcare's share price for today is €0.024.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Assurance Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Assurance Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7IQ vs IBM, ACN, FISV: EV-to-EBITDA Comparison
For the Information Technology Services subindustry, Assurance Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Assurance Healthcare EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Assurance Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Assurance Healthcare's EV-to-EBITDA falls into.
Assurance Healthcare's current Enterprise Value is €13.40 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Assurance Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Assurance Healthcare (FRA:7IQ) has a EV-to-EBITDA of -31.01 as of Aug. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Assurance Healthcare. According to the industry distribution chart, Assurance Healthcare ranks #999999 out of 1962 companies in the Software industry.
Is Assurance Healthcare's EV-to-EBITDA too high?
Assurance Healthcare's current EV-to-EBITDA is -31.01. Based on the distribution chart, Assurance Healthcare ranks #999999 out of 1962 companies in the Software industry, which is in the bottom quartile relative to peers.
How does Assurance Healthcare's EV-to-EBITDA compare to IBM and ACN?
According to the Software industry distribution chart, Assurance Healthcare ranks #999999 out of 1962 companies for EV-to-EBITDA. This places Assurance Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 10.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.41, based on 1,962 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Assurance Healthcare. For the Software industry, the median EV-to-EBITDA is 10.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Assurance Healthcare's current EV-to-EBITDA is -31.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Assurance Healthcare stock overvalued right now?
Assurance Healthcare (FRA:7IQ) has a current EV-to-EBITDA of -31.01. The current EV-to-EBITDA is -31.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Assurance Healthcare (FRA:7IQ), the current EV-to-EBITDA is -31.01 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Assurance Healthcare Ltd, formerly Revez Corp Ltd is an investment holding company. It has two operating segments Managed healthcare solutions segment includes providing managed healthcare solutions to corporations by establishing an extensive network of medical service providers to deliver healthcare services to the employees of corporations. and Corporate segment consists of investment holding company which does not meet any of the quantitative threshold for determining a reportable operating segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7IQ has been successfully added to your 
